stockrowMediciNova, Inc. (MNOV) vs Nordicus Partners Corporation (NORD)
- MediciNova, Inc. MNOV 1.45 0.00%
- Nordicus Partners Corporation NORD 3.40 −8.85%
MediciNova, Inc. and Nordicus Partners Corporation are both Biotechnology companies. MediciNova, Inc. is the larger, with a market value of $71.4M against $63.2M — 1.1× the size. Nordicus Partners Corporation grew revenue faster over the last twelve months: −71.7% against −82.2%. Nordicus Partners Corporation has the higher net margin (0.00% vs −1,168.3%) and the higher return on invested capital (−4.43% vs −62.5%). Across the 16 metrics below, Nordicus Partners Corporation leads on 13 and MediciNova, Inc. on 3.
Valuation
Profitability
| Metric | MNOV | NORD | Biotechnology median |
|---|---|---|---|
| Gross margin | 37.76% | 70.18% | 65.16% |
| Operating margin | (1,287.53%) | 0.00% | 0.00% |
| Net margin | (1,168.31%) | 0.00% | 0.00% |
| Free cash flow margin | (991.31%) | 0.00% | 0.00% |
| Return on equity | (25.56%) | (8.06%) | (50.12%) |
| Return on assets | (23.83%) | (6.80%) | (45.60%) |
| Return on invested capital | (62.48%) | (4.43%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack